These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6981577)

  • 21. [Beta-adrenergic inhibitors and portal hypertension].
    Lebrec D
    Therapie; 1985; 40(6):403-6. PubMed ID: 2868535
    [No Abstract]   [Full Text] [Related]  

  • 22. Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis.
    Kiire CF
    BMJ; 1989 May; 298(6684):1363-5. PubMed ID: 2502256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
    Wruck U; Wermke W
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of first variceal bleeding: new prospects.
    Hamid S; Jafri W
    J Pak Med Assoc; 1992 Feb; 42(2):47-51. PubMed ID: 1349361
    [No Abstract]   [Full Text] [Related]  

  • 26. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The range of renal insufficiency during ascitogenous cirrhosis].
    Andronescu M; Surdu I; Ioniţă C; Tudor S
    Med Interna (Bucur); 1969 Feb; 21(2):211-20. PubMed ID: 5305185
    [No Abstract]   [Full Text] [Related]  

  • 28. Portal hypertension, propranolol, and hepatic encephalopathy.
    Lancet; 1982 Oct; 2(8303):879-80. PubMed ID: 6126739
    [No Abstract]   [Full Text] [Related]  

  • 29. Ideal treatment of portal hypertension in 1985.
    Conn HO
    Clin Gastroenterol; 1985 Jan; 14(1):259-88. PubMed ID: 3886215
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices and ascites. Experimental design and preliminary results.
    Conn HO; Lindenmuth WW
    Am J Surg; 1969 May; 117(5):656-61. PubMed ID: 4892953
    [No Abstract]   [Full Text] [Related]  

  • 31. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol and portal hypertension: should kids be on the block?
    Schreiber RA
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):10-1. PubMed ID: 10400096
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-blockers in portal hypertension: variation on a theme.
    Brady CE
    Am J Gastroenterol; 1992 Jul; 87(7):921-2. PubMed ID: 1615953
    [No Abstract]   [Full Text] [Related]  

  • 34. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis.
    Pérez-Ayuso RM; Piqué JM; Bosch J; Panés J; González A; Pérez R; Rigau J; Quintero E; Valderrama R; Viver J
    Lancet; 1991 Jun; 337(8755):1431-4. PubMed ID: 1675316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cimetidine on portal hypertension in cirrhotic patients.
    Burroughs AK; Walt R; Dunk A; Jenkins W; Sherlock S; Mackie S; Dick R
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1159-60. PubMed ID: 6803877
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological therapy of portal hypertension].
    Miotti T; Reichen J
    Schweiz Med Wochenschr; 1985 Oct; 115(42):1468-75. PubMed ID: 2866582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol in portal hypertension: problems in paradise?
    Conn HO
    Hepatology; 1984; 4(3):560-4. PubMed ID: 6609871
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.